相关实验视频
Updated: Jun 12, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
在抗IgLON5疾病的临床表现和抗体机制
1Neurology Service, Sleep Disorder Centre, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, CIBERNED: CB06/05/0018-ISCIII, Barcelona, Spain.
抗IgLON5疾病是一种罕见的自身免疫神经系统疾病. 最近的发现支持了自身免疫假设,强调了抗体介导的损伤和神经退行.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 抗IgLON5疾病是最近发现的一种神经疾病,其特点是自身免疫和神经退行症的融合.
- 诊断挑战来自症状异质性,模仿其他神经疾病和有限的意识.
- 了解病理生理学对于诊断和管理至关重要.
研究的目的:
- 审查了解Anti-IgLON5疾病病理生理学的最新进展.
- 总结关键的病理特征,并加强自身免疫假设.
- 突出潜在的诊断和监测进展.
主要方法:
- 审查最近的尸检研究和免疫学调查.
- 使用正子发射断层扫描 (PET) 的体内陶沉积研究的分析.
- 在动物模型中对被动转移研究的评估.
主要成果:
- 精细的病理特征支持Anti-IgLON5疾病的自身免疫基础.
- 受抗体介导的IgLON5集群的减少和细胞骨的改变是相关的.
- 动物模型显示在被动抗体转移后的神经炎症和神经退行.
结论:
- 反-IgLON5疾病的自身免疫假设得到了最近证据的支持.
- 神经元损伤的生物标志物和tau PET成像可能有助于疾病监测.
- 为了治疗的发展,需要对病变发生的进一步研究.
更多相关视频
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
相关概念视频
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Humoral Immune Responses
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.